Marcus Schlemmer

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi request reprint The role of hyperthermia in combined treatment in the management of soft tissue sarcoma
    Rolf D Issels
    University Hospital Medical Center Grosshadern Medical Clinic III, GSF National Research Center for the Environment and Health, 81377 Munich, Germany
    Curr Oncol Rep 8:305-9. 2006
  2. pmc Analysis of orthopedic surgery of bone metastases in breast cancer patients
    Bernd Wegener
    Orthopedic Oncology, Department of Orthopedic Surgery, Ludwig Maximilians University Munich, Marchioninistrasse 15, D 81377, Munchen, Gemany
    BMC Musculoskelet Disord 13:232. 2012
  3. doi request reprint Response to nilotinib as a first-line treatment for metastatic gastrointestinal stromal tumors
    Marcus Schlemmer
    Department of Internal Medicine III Hematology Oncology, University Hospital Munich Campus Grosshadern, Munich, Germany
    J Gastrointest Cancer 43:385-7. 2012
  4. pmc Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response
    Dominik Ruttinger
    Department of Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Marchioninistrasse 15, 81377 Munich, Germany
    J Transl Med 5:43. 2007
  5. doi request reprint Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group
    M Schlemmer
    Medical Clinic and Polyclinc III, Clinic Grosshadern Munich, Ludwig Maximilian University Munich, Muenchen, Germany
    Eur J Cancer 44:2433-6. 2008
  6. ncbi request reprint Desmoid tumors and deep fibromatoses
    Marcus Schlemmer
    Medical Clinic and Polyclinic III, Clinic Grosshadern Munich, Ludwig Maximilian University Munich, Marchioninistrasse 15, Muenchen D 81377, Germany
    Hematol Oncol Clin North Am 19:565-71, vii-viii. 2005
  7. doi request reprint Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS)
    M Schlemmer
    Department of Internal Medicine III, Klinikum Grosshadern Medical Centre, Ludwig Maximilians University Munich, Germany
    Int J Hyperthermia 26:127-35. 2010
  8. ncbi request reprint [Principles, technology and indication of hyperthermia and part body hyperthermia]
    M Schlemmer
    Medizinische Klinik und Poliklinik III, Klinikum Grosshadern der Universität München
    Radiologe 44:301-9. 2004
  9. pmc Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial
    Marcus Schlemmer
    Depart Medical Oncology Klinikum Grosshadern, Munich, Germany
    Eur J Med Res 16:206-12. 2011
  10. ncbi request reprint Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas
    Marcus Schlemmer
    Department of Internal Medicine III, Klinikum Grosshadern Medical Center, Munich, Germany
    Oncology 71:32-9. 2006

Detail Information

Publications24

  1. ncbi request reprint The role of hyperthermia in combined treatment in the management of soft tissue sarcoma
    Rolf D Issels
    University Hospital Medical Center Grosshadern Medical Clinic III, GSF National Research Center for the Environment and Health, 81377 Munich, Germany
    Curr Oncol Rep 8:305-9. 2006
    ..This short overview summarizes the results of the combination with regional hyperthermia as a new treatment strategy to open a new therapeutic window...
  2. pmc Analysis of orthopedic surgery of bone metastases in breast cancer patients
    Bernd Wegener
    Orthopedic Oncology, Department of Orthopedic Surgery, Ludwig Maximilians University Munich, Marchioninistrasse 15, D 81377, Munchen, Gemany
    BMC Musculoskelet Disord 13:232. 2012
    ..Breast cancer is the most common malignancy and the second leading cause of death in women. Because bone metastases are a common finding in patients with breast cancer, they are of major clinical concern...
  3. doi request reprint Response to nilotinib as a first-line treatment for metastatic gastrointestinal stromal tumors
    Marcus Schlemmer
    Department of Internal Medicine III Hematology Oncology, University Hospital Munich Campus Grosshadern, Munich, Germany
    J Gastrointest Cancer 43:385-7. 2012
    ....
  4. pmc Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response
    Dominik Ruttinger
    Department of Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Marchioninistrasse 15, 81377 Munich, Germany
    J Transl Med 5:43. 2007
    ..This paper reports on the first clinical experience and evidence of an immune response in patients suffering from NSCLC...
  5. doi request reprint Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group
    M Schlemmer
    Medical Clinic and Polyclinc III, Clinic Grosshadern Munich, Ludwig Maximilian University Munich, Muenchen, Germany
    Eur J Cancer 44:2433-6. 2008
    ..The objective of this retrospective study was to assess the anti-tumour activity of this compound in a multicentre setting...
  6. ncbi request reprint Desmoid tumors and deep fibromatoses
    Marcus Schlemmer
    Medical Clinic and Polyclinic III, Clinic Grosshadern Munich, Ludwig Maximilian University Munich, Marchioninistrasse 15, Muenchen D 81377, Germany
    Hematol Oncol Clin North Am 19:565-71, vii-viii. 2005
    ..Treatment primarily is surgical, although radiation or systemic therapy can be beneficial to the patient when surgery is not feasible. This article highlights the biology and clinical features of desmoid tumors...
  7. doi request reprint Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS)
    M Schlemmer
    Department of Internal Medicine III, Klinikum Grosshadern Medical Centre, Ludwig Maximilians University Munich, Germany
    Int J Hyperthermia 26:127-35. 2010
    ....
  8. ncbi request reprint [Principles, technology and indication of hyperthermia and part body hyperthermia]
    M Schlemmer
    Medizinische Klinik und Poliklinik III, Klinikum Grosshadern der Universität München
    Radiologe 44:301-9. 2004
    ..The results shows, that response to treatment can be improved by hyperthermia...
  9. pmc Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial
    Marcus Schlemmer
    Depart Medical Oncology Klinikum Grosshadern, Munich, Germany
    Eur J Med Res 16:206-12. 2011
    ..The safety profile of imatinib based on adverse event assessment is favorable. Imatinib is generally well tolerated in patients with gastrointestinal stromal tumors...
  10. ncbi request reprint Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas
    Marcus Schlemmer
    Department of Internal Medicine III, Klinikum Grosshadern Medical Center, Munich, Germany
    Oncology 71:32-9. 2006
    ..We report phase II data of high-dose chemotherapy and peripheral blood stem cell (PBSC) rescue in patients with MSTS responding to AI-G chemotherapy...
  11. doi request reprint Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapy
    Marcus Schlemmer
    Department of Internal Medicine III, University Hospitals Großhadern, Ludwig Maximilians University Munich, Marchioninistr 15, 81377 Munich, Germany
    Eur J Radiol 77:312-8. 2011
    ..The aim of this pilot study was the evaluation of CT perfusion patterns in metastatic GIST lesions under specific molecular therapy with sunitinib or imatinib both in responders and non-responders...
  12. ncbi request reprint Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults
    M Fiegl
    Department of Internal Medicine III, University Hospital Grosshadern, Ludwig Maximilians University, Marchioninistrasse 15, 81377 Munich, Germany
    Int J Hyperthermia 20:661-70. 2004
    ..A median of four courses of ICE were administered with RHT on days 1 and 3 (60 min, T(max) 42 degrees C)...
  13. ncbi request reprint Ifosfamide with regional hyperthermia in soft-tissue sarcomas
    M Schlemmer
    Department of Internal Medicine III, Klinikum Grosshadern Medical Center, Ludwig Maximilians University Munich, Munich, Germany
    Oncology 65:76-9. 2003
    ..The combination with regional hyperthermia as a new treatment strategy seems to open a new therapeutic window...
  14. ncbi request reprint Immunotherapy of lung cancer: an update
    Dominik Ruttinger
    Chirurgische Klinik und Poliklinik, Abteilung für Transfusionsmedizin und Hämostaseologie, Klinikum Grosshadern, Ludwig Maximilians Universitat Munchen, Munchen, Germany
    Onkologie 29:33-8. 2006
    ..Although there seems to be a promising future for immunotherapy in lung cancer, presently there is not standard immunotherapy available for clinical routine...
  15. ncbi request reprint The cause of subchondral bone cysts in osteoarthrosis: a finite element analysis
    Hans D Dürr
    Department of Orthopaedics and Orthopaedic Surgery, Ludwig Maximilians University Munich, Klinikum Grosshadern, Marchioninistr 15, DE 81366 Munich, Germany
    Acta Orthop Scand 75:554-8. 2004
    ..The etiology of subchondral bone cysts in arthrotic joints is unclear...
  16. ncbi request reprint [Gastrointestinal stromal tumors]
    M Schlemmer
    Medizinische Klinik und Poliklinik III, Ludwig Maximilians Universitat, Munich
    Dtsch Med Wochenschr 128:2015-9. 2003
  17. ncbi request reprint Current trials and new aspects in soft tissue sarcoma of adults
    R D Issels
    Department of Internal Medicine III, Klinikum Grosshadern Medical Center, Ludwig Maximilians University, Munich, Germany
    Cancer Chemother Pharmacol 49:S4-8. 2002
    ..Therefore, systemic chemotherapy has been integrated either after (adjuvant) or before (neoadjuvant) optimal local treatment by surgery and radiotherapy in HR-STS...
  18. ncbi request reprint Paramagnetic thermosensitive liposomes for MR-thermometry
    L H Lindner
    Department of Medicine III, University Hospital Grosshadern, CCG Hyperthermia, GSF National Research Center for Environment and Health, Ludwig Maximilians University, Munich, Germany
    Int J Hyperthermia 21:575-88. 2005
    ..Nevertheless, before entering clinical trials they have to be studied in more detail with regard to dose, pharmacokinetics and toxicity...
  19. doi request reprint Tissue levels of reduced folates in patients with colorectal carcinoma after infusion of folinic acid at various dose levels
    Marcus Schlemmer
    Department of Internal Medicine III, Ludwig Maximilians University Grobetahadern, Marchioninistr 15, Munich, Germany
    Clin Cancer Res 14:7930-4. 2008
    ..However, the optimal dose of FA is still debated. We investigated reduced folate pools in various tissues from patients with CRC without and after prior administration of FA...
  20. ncbi request reprint Impact of human herpesvirus-6 after haematopoietic stem cell transplantation
    Marcus Hentrich
    Department of Internal Medicine III, University Hospital Grosshadern, Germany
    Br J Haematol 128:66-72. 2005
    ..31], Epstein-Barr virus coinfection (OR 8.89) and unrelated donor transplantation (OR 5.67) indicating an increased stage of immunosuppression...
  21. ncbi request reprint Gene expression profiling in sarcomas
    Katharina Tschoep
    Medizinische Klinik und Poliklinik III, Ludwig Maximilians University, Medical Center Grosshadern, Munich, Germany
    Crit Rev Oncol Hematol 63:111-24. 2007
    ....
  22. ncbi request reprint [Gene expression analysis using DNA microarrays in soft tissue and bone tumors]
    K Tschoep
    Medizinische Klinik und Poliklinik III, Ludwig Maximilians Universitat, Klinikum Grosshadern, Munich
    Dtsch Med Wochenschr 128:2030-6. 2003
  23. ncbi request reprint Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg
    John R Zalcberg
    Department of Medical Oncology, Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A Beckett Street, Melbourne, VIC 8006, Australia
    Eur J Cancer 41:1751-7. 2005
    ..1% of patients were still alive and progression free one year after cross-over. We conclude that a cross-over to high-dose imatinib is feasible and safe in GIST patients who progress on low-dose therapy...
  24. doi request reprint Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up
    P G Casali
    Department of Cancer Medicine, Istituto Nazionale dei Tumori, Milan, Italy
    Ann Oncol 19:ii89-93. 2008